Search
for
Sort by
Research 331–360 of 1000+
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- Antiandrogens and Androgen Inhibitors
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- JAK inhibitors for the treatment of alopecia areata
- 706 Predictive modeling of patient response to JAK/STAT inhibitors and dynamic patient-matching
- 708 Promotion of hair growth in alopecia areata by topical treatment of HDAC inhibitors
- SAT-288 Successful Virilization of a PAIS Patient with a Missense Mutation In The Ligand-binding Domain Of The Androgen Receptor with Combined High-dose Testosterone and Aromatase Inhibitor
- P123 : Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and metaanalysis
- Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures
- PD59-09 PHOSPHODIESTERASE INHIBITORS COULD REVERSE THE PROLIFERATION OF BPH EPITHELIAL CELLS INDUCED BY CD8+ T CELLS IN LOW ANDROGEN CONDITION
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Design, synthesis and structure-activity relationships studies on steroidal aromatase and 5α-reductase inhibitors as anti-tumors
- Re: Inhibitors of 5α-Reductase-Related Side Effects in Patients Seeking Medical Care for Sexual Dysfunction
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Downregulation of nuclear factor-kappaB activation in human keratinocytes by melanogenesis inhibitors
- Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor
- A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- A New Look at the 5?-Reductase Inhibitor Finasteride
- Midazolam Inhibits Hippocampal Long-Term Potentiation and Learning through Dual Central and Peripheral Benzodiazepine Receptor Activation and Neurosteroidogenesis
- Corticosterone inhibits GAS6 to govern hair follicle stem-cell quiescence
- Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles